.
Advantages of implementing Deep Learning for tissue segmentation and cell detection in multiplex IF studies
OracleBio Case Study

Note: Permission has been granted for the use of this material
Study Background
Advantages of implementing Deep Learning for tissue segmentation and cell detection in multiplex IF studies
Utilize AI Deep Learning approaches in Visiopharm software to enhance the performance of:
- Tumor / stroma ROI segmentation across different cancer tissues
- Detection of different phenotypic cells within TME across samples
Sample Details
8-plex mIF stained Tissue Microarray (TMA), containing 4 different cancers across 143 cores
Staining
mIF Panel: CD3, CD4, CD8, FOXP3, CD68/CD163, PD-1, PD-L1 & pan-CK / SOX10 cocktail
Analysis
Image analysis was performed using Visiopharm software.
View the Case Study
Click the thumbnail below to view the case study PDF:
Or watch the video case study presentation:
Benefits of Working with OracleBio for your Clinical Studies:
- Data you can trust – We have thorough quality control procedures in place throughout our workflow to ensure the data we provide is of a high-quality standard
- Work alongside Clinical Project managers – experienced with ensuring data parity between time-separated batches of clinical samples

